The online community and resource center for all in life science related disciplines (BIOSCIENTISTS)
February 21, 2020, 08:30:39 am *
Welcome, Guest. Please login or register.

Login with username, password and session length
News: Over 3000 Nigerian Life scientists are on ground & willing to provide answers to your bioscience & research questions/problems; You only need to post it online Now! (Requires very brief registration)

To be kept up to date on interesting posts in this forum,  LIKE our facebook page!
.
 
   Home   Help Login Register  
Pages: [1]
  Print  
Author Topic: Researchers identify key enzyme in DNA repair pathway- (Aug, 2010)  (Read 2462 times)
0 Members and 1 Guest are viewing this topic.
Francis Umeoguaju
Administrator
Expert in Bioscience Issues
*****
Posts: 657



WWW
« on: August 23, 2010, 04:24:01 pm »


Researchers identify key enzyme in DNA repair pathway- (Aug, 2010 bioscience headlines)

Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer.

Scientists from The University of Texas MD Anderson Cancer Center and the Life Sciences Institute of Zhejiang University in China report the discovery of the enzyme and its role in repairing DNA damage called cross-linking in the Science Express advance online publication of Science.

"This pathway that repairs cross-linking damage is a common factor in a variety of cancers, including breast cancer and especially in ovarian cancer. If the pathway is active, it undoes the therapeutic effect of cisplatin and similar therapies," said co-corresponding author Junjie Chen, Ph.D., professor and chair of MD Anderson's Department of Experimental Radiation Oncology.

The platinum-based chemotherapies cisplatin, carboplatin and oxaliplatin work by causing DNA cross-linking in cancer cells, which blocks their ability to divide and leads to cell death. Cross-linking occurs when one of the two strands of DNA in a cell branches out and links to the other strand.

Cisplatin and similar drugs are often initially effective against ovarian cancer, Chen said, but over time the disease becomes resistant and progresses.

Scientists have known that the protein complex known as FANCI-FANCD2 responds to DNA damage and repairs cross-linking, but the details of how the complex works have been unknown. "The breakthrough in this research is that we finally found an enzyme involved in the repair process," Chen said. Read Full story>>

Sourced from <http://www.biologynews.net/archives/2010/07/30/researchers_identify_key_enzyme_in_dna_repair_pathway.html>


Feel free to post your comments about this story here. Free and brief registration into our bioscience community is required before you can post your comments.
You can also access other interesting & Recent bioscience stories here.

Click here, to subscribe for our monthly free enewletters


You can also suggest new stories here


Logged

Chances favours the trained minds
Pages: [1]
  Print  
 
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.11 | SMF © 2006-2009, Simple Machines LLC
SMFAds for Free Forums
Valid XHTML 1.0! Valid CSS!